823 related articles for article (PubMed ID: 16849680)
1. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
2. Effects of
Li WQ; Zhang JY; Ma JL; Li ZX; Zhang L; Zhang Y; Guo Y; Zhou T; Li JY; Shen L; Liu WD; Han ZX; Blot WJ; Gail MH; Pan KF; You WC
BMJ; 2019 Sep; 366():l5016. PubMed ID: 31511230
[TBL] [Abstract][Full Text] [Related]
3. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
Ma JL; Zhang L; Brown LM; Li JY; Shen L; Pan KF; Liu WD; Hu Y; Han ZX; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; You WC; Gail MH
J Natl Cancer Inst; 2012 Mar; 104(6):488-92. PubMed ID: 22271764
[TBL] [Abstract][Full Text] [Related]
4. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.
Gail MH; You WC; Chang YS; Zhang L; Blot WJ; Brown LM; Groves FD; Heinrich JP; Hu J; Jin ML; Li JY; Liu WD; Ma JL; Mark SD; Rabkin CS; Fraumeni JF; Xu GW
Control Clin Trials; 1998 Aug; 19(4):352-69. PubMed ID: 9683311
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
6. A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions.
Gail MH; You WC
J Nutr; 2006 Mar; 136(3 Suppl):813S-815S. PubMed ID: 16484571
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
9. An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
You WC; Chang YS; Heinrich J; Ma JL; Liu WD; Zhang L; Brown LM; Yang CS; Gail MH; Fraumeni JF; Xu GW
Eur J Cancer Prev; 2001 Jun; 10(3):257-63. PubMed ID: 11432713
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.
You WC; Zhang L; Gail MH; Ma JL; Chang YS; Blot WJ; Li JY; Zhao CL; Liu WD; Li HQ; Hu YR; Bravo JC; Correa P; Xu GW; Fraumeni JF
Int J Epidemiol; 1998 Dec; 27(6):941-4. PubMed ID: 10024185
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
12. Antioxidants, Helicobacter pylori and stomach cancer in Venezuela.
de Sanjosé S; Muñoz N; Sobala G; Vivas J; Peraza S; Cano E; Castro D; Sanchez V; Andrade O; Tompkins D; Schorah CJ; Axon AT; Benz M; Oliver W
Eur J Cancer Prev; 1996 Feb; 5(1):57-62. PubMed ID: 8664811
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China.
Wang GQ; Dawsey SM; Li JY; Taylor PR; Li B; Blot WJ; Weinstein WM; Liu FS; Lewin KJ; Wang H
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):161-6. PubMed ID: 8049638
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
[TBL] [Abstract][Full Text] [Related]
15. Association Between Lifestyle Factors, Vitamin and Garlic Supplementation, and Gastric Cancer Outcomes: A Secondary Analysis of a Randomized Clinical Trial.
Guo Y; Li ZX; Zhang JY; Ma JL; Zhang L; Zhang Y; Zhou T; Liu WD; Han ZX; Li WQ; Pan KF; You WC
JAMA Netw Open; 2020 Jun; 3(6):e206628. PubMed ID: 32589229
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
17. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
18. Re: Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
Mera R; Fontham ET; Bravo LE; Bravo JC; Piazuelo MB; Camargo MC; Correa P
J Natl Cancer Inst; 2006 Oct; 98(19):1426. PubMed ID: 17018791
[No Abstract] [Full Text] [Related]
19. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.
Zhang L; Gail MH; Wang YQ; Brown LM; Pan KF; Ma JL; Amagase H; You WC; Moslehi R
Am J Clin Nutr; 2006 Oct; 84(4):912-9. PubMed ID: 17023720
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
